ifosfamide has been researched along with Serotonin Syndrome in 1 studies
Serotonin Syndrome: An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methylene blue has been used not only as a diagnostic agent, but also as an agent in the treatment of ifosfamide-induced encephalopathy (IIE) for several years." | 5.38 | Suspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy. ( Fisher, DC; McDonnell, AM; Rybak, I; Wadleigh, M, 2012) |
| "Methylene blue has been used not only as a diagnostic agent, but also as an agent in the treatment of ifosfamide-induced encephalopathy (IIE) for several years." | 1.38 | Suspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy. ( Fisher, DC; McDonnell, AM; Rybak, I; Wadleigh, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McDonnell, AM | 1 |
| Rybak, I | 1 |
| Wadleigh, M | 1 |
| Fisher, DC | 1 |
1 other study available for ifosfamide and Serotonin Syndrome
| Article | Year |
|---|---|
Suspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy.
Topics: Brain Diseases; Humans; Ifosfamide; Methylene Blue; Serotonin Syndrome | 2012 |